These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 2906184)

  • 1. Sulphasalazine and new related compounds.
    Campieri M; Gionchetti P; Belluzzi A; Brignola C; Tabanelli GM; Forresan F; Miglioli M; Barbara L
    Trop Gastroenterol; 1988; 9(4):179-83. PubMed ID: 2906184
    [No Abstract]   [Full Text] [Related]  

  • 2. Sulphasalazine in ulcerative colitis.
    Drug Ther Bull; 1967 Nov; 5(24):93-4. PubMed ID: 4384228
    [No Abstract]   [Full Text] [Related]  

  • 3. Proceedings: A controlled therapeutic trial of long-term maintenance treatment of ulcerative colitis with sulphasalazine (salazopyrin).
    Dissanayake AS; Truelove SC
    Gut; 1973 Oct; 14(10):818. PubMed ID: 4148469
    [No Abstract]   [Full Text] [Related]  

  • 4. Preventive effects of sulphasalazine on colorectal carcinogenesis in mice with ulcerative colitis.
    Suzuki S; Sakamoto S; Mitamura T; Sassa S; Kudo H; Yamashita Y
    In Vivo; 2000; 14(3):463-6. PubMed ID: 10904883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Olsalazine versus sulphasalazine for relapse prevention in ulcerative colitis: a multicenter study.
    Nilsson A; Danielsson A; Löfberg R; Benno P; Bergman L; Fausa O; Florholmen J; Karvonen AL; Kildebo S; Kollberg B
    Am J Gastroenterol; 1995 Mar; 90(3):381-7. PubMed ID: 7872274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Male infertility due to sulphasalazine therapy of ulcerous colitis.
    Ragni G; Bestetti O; Lombardi C; Wyssling H; Di Pietro R
    Acta Eur Fertil; 1983; 14(3):223-6. PubMed ID: 6142578
    [No Abstract]   [Full Text] [Related]  

  • 7. Proceedings: Effects of sulphasalazine (Salazopyrin) on faecal flora in patients with inflammatory bowel disease.
    Lendrum R; Walker JG; West B; Hill MJ
    Gut; 1974 Apr; 15(4):344. PubMed ID: 4151868
    [No Abstract]   [Full Text] [Related]  

  • 8. Sulphasalazine and oxidant scavenging in ulcerative colitis.
    Halliwell B
    Lancet; 1987 Sep; 2(8559):635. PubMed ID: 2887928
    [No Abstract]   [Full Text] [Related]  

  • 9. Mechanism of sulphasalazine action in ulcerative colitis.
    Rachmilewitz D; Sharon P; Ligumsky M; Zor U
    Lancet; 1978 Oct; 2(8096):946. PubMed ID: 81963
    [No Abstract]   [Full Text] [Related]  

  • 10. [Immunosuppressive therapy in ulcerative rectocolitis. Long-term assessment of results].
    Aresu G; Mereu S; Frongia N; Casula G; Uccheddu A
    Minerva Med; 1982 Apr; 73(14):767-86. PubMed ID: 6122191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Letter: Prostaglandins, ulcerative colitis, and sulphasalazine.
    Gould SR
    Lancet; 1975 Nov; 2(7942):988. PubMed ID: 53480
    [No Abstract]   [Full Text] [Related]  

  • 12. Bullous pemphigoid initially localized to sites of burns (scalds) in a patient on sulphasalazine for ulcerative colitis.
    Quartey-Papafio CM; Hudson PM
    Clin Exp Dermatol; 1994 May; 19(3):281. PubMed ID: 7913427
    [No Abstract]   [Full Text] [Related]  

  • 13. Raynaud's phenomenon induced by sulphasalazine in a case of chronic ulcerative colitis.
    Ahmad J; Siddiqui MA; Khan AS; Afzall S
    J Assoc Physicians India; 1984 Apr; 32(4):370. PubMed ID: 6146597
    [No Abstract]   [Full Text] [Related]  

  • 14. 5-ASA enema versus oral sulphasalazine in maintaining remission in ulcerative colitis.
    Andreoli A; Spinella S; Levenstein S; Prantera C
    Ital J Gastroenterol; 1994 Apr; 26(3):121-5. PubMed ID: 7914759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of ulcerative colitis with oral mesalamine: advances in drug formulation, efficacy expectations and dose response, compliance, and chemoprevention.
    Sandborn WJ
    Rev Gastroenterol Disord; 2006; 6(2):97-105. PubMed ID: 16699478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sulphasalazine is a potent inhibitor of prostaglandin 15-hydroxydehydrogenase: possible basis for therapeutic action in ulcerative colitis.
    Hoult JR; Moore PK
    Br J Pharmacol; 1978 Sep; 64(1):6-8. PubMed ID: 29685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostaglandins and mechanism of action of sulphasalazine in ulcerative colitis.
    Moore PK; Hoult JR; Laurie A
    Lancet; 1978 Jul; 2(8080):98-9. PubMed ID: 78320
    [No Abstract]   [Full Text] [Related]  

  • 18. [ A case of ulcerative colitis of the large intestine].
    Ruszkowski J
    Wiad Lek; 1967 Jan; 20(2):165-7. PubMed ID: 4382890
    [No Abstract]   [Full Text] [Related]  

  • 19. Maintenance of remission in ulcerative colitis. Effect of an orally absorbed mast cell stabilizer.
    Davies PS; Rhodes J; Counsell B; Evans BK
    Am J Gastroenterol; 1980 Aug; 74(2):150-3. PubMed ID: 6108711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparative efficacy of mezakol and sulfasalazine in treating chronic relapsing ulcerative colitis].
    Rogozina VA; Rumiantsev VG
    Eksp Klin Gastroenterol; 2003; (1):58-9, 183. PubMed ID: 12664788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.